Acer therapeutics announces $1.5m private placement

Newton, mass., nov. 30, 2022 (globe newswire) -- acer therapeutics inc. (nasdaq: acer), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today announced that it has entered into definitive agreements with its ceo as well as its chairman for a private placement of its securities for gross proceeds of $1.5 million.
ACER Ratings Summary
ACER Quant Ranking